High expression of human clotting factor IX cDNA in myoblasts C2C12 cells and C3H mice

Science in China, Series C: Life Sciences

Volumn 40, Issue 4, 1997, Pages 371-378

  Wang, Hongwei ^a   Bao, Yun ^a   Lu, Daru ^a   Qiu, Xinfang ^a   Xue, Jinglun ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Gene therapy; Gene transfer; Human clotting factor IX; Myoblasts

Indexed keywords

HUMAN HERPESVIRUS 5; UNIDENTIFIED RETROVIRUS;

EID: 1542681373     PISSN: 10069305     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02881730     Document Type: Article

References (15)

1. Lu Daru, Zhou Jiemin, Zheng Bing et al., Stage I clinical trial of gene therapy for hemophilia B, Science in China , Ser. B, 1993, 36(11): 1342.
2. Barr, E., Leiden, J. M., Systemic delivery of recombinant proteins by genetically modified myoblasts. Science, 1991, 254: 1507.
3. Dhawan, J., Pan, L. C., Pavlath, G. K. et al., Systemic delivery of human growth hormone by injection of genetically engineered myoblasts, Science, 1991, 254: 1509.
4. Yao, S. -N., Smith, K. J., Kurachi, K., Primary myoblast-mediated gene transfer: persistent expression of human factor IX in mice. Gene Therapy, 1994, 1: 99.
5. Sambrook, J., Fritsch, E. F., Maniatis, T., Molecular Cloning : A Laboratory Mannual, 2nd ed., NewYork: Cold Spring Harbor Laboratory Press, 1989.
6. Zhou Jiemin, Dai Yifan, Qiu Xinfang et al., Expression of human factor IX cDNA in mice by implants of genetically modified skin fibroblasts from a hemophilia B patient, Science in China, Ser. B, 1993, 36(9): 1082.
7. Dai Yifan, Qiu Xinfang, Xue Jinglun et al., High efficient transfer and expression of human clotting factor IX cDNA in cultured human primary skin fibroblasts from hemophilia B patient by retroviral vectors, Science in China, Ser. B, 1992, 35(2): 183.
8. Wang Hongwei, Zheng Bing, Xue Jinglun et al., Expression of human clotting factor IX with EBV shuttle vector, Chinese Science Bulletin, 1995, 40(21): 1829.
9. Yao, S. -N., Kurachi, K., Expression of human factor IX in mice after injection of genetically modified myoblasts, Proc. Nat. Acad. Sci. USA, 1992, 89: 3357.
10. Dai, Y., Roman, M., Naviaux, R. K. et al., Gene therapy via primary myoblasts: Long-term expression of factor IX protein following transplantation in vivo, Proc. Nat. Acad. Sci. USA, 1992, 89: 10892.
11. Jaynes, J. B., Chamberlain, J. S., Buskin, J. N. et al., The muscle creatinekinase gene is regulated by multiple upstream elements, including a muscle-specific enhancer, Mol. Cell. Biol., 1988, 8: 62.
12. Roman, M., Axelrod, J. H., Dai, Y. et al., Circulating human or caninefactor IX from retroviraliy transduced primary myoblasts and established myoblast cell lines grafted into murine skeletal muscle. Somatic Cell Mol. Genet., 1991, 18: 247.
13. Pavlath, G. K., Rando, T. T. Blau, H. M., Transient immunosuppressive treatment leads to long-term retention of allogeneic myoblasts in hybridmyofibers, The Journal of Cell Biology, 1993, 127: 1923.
14. Zhou Jiemin, Qiu Xinfang, Lu Daru et al., Long-term expression of human factor IX cDNA in rabbits, Science in China, Ser. B. 1993, 36(11): 1333.
15. Gibson, A. J., Karasinski, J., Relvas, J. et al., Dermal fibroblasts convert to a myogenic lineage in mdx mouse muscle, Journal of Cell Science, 1995, 108: 207.